|
CN101979095A
(zh)
|
2001-05-02 |
2011-02-23 |
普渡研究基金会 |
巨噬细胞介导的疾病的治疗和诊断
|
|
US8043602B2
(en)
|
2002-02-07 |
2011-10-25 |
Endocyte, Inc. |
Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
|
|
US8043603B2
(en)
|
2002-02-07 |
2011-10-25 |
Endocyte, Inc. |
Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
|
|
AU2003261723A1
(en)
|
2002-08-27 |
2004-03-19 |
Takeda Chemical Industries, Ltd. |
Cxcr4 antagonist and use thereof
|
|
WO2005103721A1
(en)
*
|
2004-04-20 |
2005-11-03 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 4 (cxcr4)
|
|
AU2006203826A1
(en)
|
2005-01-07 |
2006-07-13 |
Emory University |
CXCR4 antagonists for the treatment of HIV infection
|
|
WO2006091112A1
(en)
*
|
2005-02-22 |
2006-08-31 |
Genesis Reasearch And Development Corporation Limited |
Compositions for the delivery of rna interference molecules and methods for their use
|
|
US7825088B2
(en)
*
|
2005-04-25 |
2010-11-02 |
The Cbr Institute For Biomedical Research, Inc. |
Methods for the treatment of multiple myeloma
|
|
US8569280B2
(en)
|
2005-04-25 |
2013-10-29 |
Immune Disease Institute |
Methods for the treatment of multiple myeloma
|
|
DE102005023170A1
(de)
*
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
|
WO2006126188A2
(en)
*
|
2005-05-25 |
2006-11-30 |
Hadasit Medical Research Services And Development Ltd. |
Cxcr4 antagonists for wound healing and re-epithelialization
|
|
EP1904183B1
(en)
|
2005-07-05 |
2014-10-15 |
Purdue Research Foundation |
Pharmaceutical composition for the treatment of osteoarthritis
|
|
US20070043012A1
(en)
|
2005-08-19 |
2007-02-22 |
Bridger Gary J |
Methods to enhance chemotherapy
|
|
US8795633B2
(en)
|
2005-09-23 |
2014-08-05 |
Purdue Research Foundation |
Multiphoton in vivo flow cytometry method and device
|
|
WO2007058322A1
(ja)
|
2005-11-18 |
2007-05-24 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
JP2009531283A
(ja)
*
|
2006-02-02 |
2009-09-03 |
アラーガン、インコーポレイテッド |
眼系疾患の処置のための組成物および方法
|
|
US8628750B2
(en)
|
2006-02-27 |
2014-01-14 |
Technische Universitat Munchen |
Cancer imaging and treatment
|
|
TW200808328A
(en)
*
|
2006-06-02 |
2008-02-16 |
Alcon Mfg Ltd |
RNAi-mediated inhibition of stromal cell-derived factor 1-related targets for treatment of neovascularization-related conditions
|
|
US8080659B2
(en)
|
2006-07-11 |
2011-12-20 |
Emory University |
CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
|
|
JP2010509570A
(ja)
|
2006-11-03 |
2010-03-25 |
パーデュー・リサーチ・ファウンデーション |
エクスビボフローサイトメトリーの方法および装置
|
|
WO2008075371A2
(en)
|
2006-12-21 |
2008-06-26 |
Biokine Therapeutics Ltd. |
T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
|
|
US8586595B2
(en)
|
2007-02-07 |
2013-11-19 |
Purdue Research Foundation |
Positron emission tomography imaging method
|
|
WO2008148001A2
(en)
|
2007-05-25 |
2008-12-04 |
Purdue Research Foundation |
Method of imaging localized infections
|
|
KR20100056508A
(ko)
*
|
2007-09-11 |
2010-05-27 |
몬도바이오테크 래보래토리즈 아게 |
폐렴 연쇄상 구균 감염의 치료를 위한 ｂｆｇｆ １－２４ 및 임의의 （ａｒｇ ８）바소프레신의 용도
|
|
BRPI0909375A2
(pt)
|
2008-03-28 |
2015-08-04 |
Altiris Therapeutics |
Moduladores de receptores de quimiocinas
|
|
JP2012507524A
(ja)
|
2008-11-04 |
2012-03-29 |
アンカー セラピューティクス，インコーポレイテッド |
Ｃｘｃｒ４受容体化合物
|
|
BRPI1009663A2
(pt)
*
|
2009-06-14 |
2016-10-11 |
Biokine Therapeutics Ltd |
"método para elevação dos níveis plaquetários em um indivíduo com essa necessidade, método de inibição de hemorragia em um indivíduo que a necessite e composição farmacêutica"
|
|
WO2011094389A2
(en)
*
|
2010-01-27 |
2011-08-04 |
Emory University |
Cxcr4 antagonists for imaging of cancer and inflammatory disorders
|
|
WO2011106703A2
(en)
|
2010-02-26 |
2011-09-01 |
Anchor Therapeutics, Inc. |
Cxcr4 receptor compounds
|
|
AU2011300818B2
(en)
*
|
2010-09-09 |
2015-11-12 |
TME Pharma AG |
SDF-1 binding nucleic acids and the use thereof in cancer treatment
|
|
US20130303460A1
(en)
|
2011-01-10 |
2013-11-14 |
Biokine Therapeutics Ltd. |
Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
|
|
EP2476441A1
(en)
|
2011-01-13 |
2012-07-18 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
|
|
US20140329809A1
(en)
|
2011-10-28 |
2014-11-06 |
Galderma Research & Development |
New leukocyte infiltrate markers for rosacea and uses thereof
|
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
|
JP6294459B2
(ja)
|
2013-03-24 |
2018-03-14 |
バイオカイン・セラピューティクス・リミテッドＢｉｏｋｉｎｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ． |
骨髄性白血病の処置方法
|
|
ES2811804T3
(es)
|
2013-10-31 |
2021-03-15 |
Biokine Therapeutics Ltd |
Un inhibidor peptídico de CXCR4 para su uso en el tratamiento de la leucemia mieloide aguda con una mutación de FLT3
|
|
AU2015212341A1
(en)
|
2014-02-03 |
2016-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of Casein kinase I inhibitors for depleting stem cells
|
|
KR101700946B1
(ko)
*
|
2014-11-11 |
2017-02-02 |
연세대학교 산학협력단 |
Ｃｘｃｒ４ 길항제를 포함하는 피부 색소침착의 예방 또는 개선용 조성물
|
|
AU2016242118B2
(en)
*
|
2015-04-02 |
2021-07-08 |
Proximagen, Llc |
Novel therapies for cancer
|
|
US10709697B2
(en)
|
2015-07-16 |
2020-07-14 |
Emory University |
Bis-amines, compositions, and uses related to CXCR4 inhibition
|
|
US10786547B2
(en)
|
2015-07-16 |
2020-09-29 |
Biokine Therapeutics Ltd. |
Compositions, articles of manufacture and methods for treating cancer
|
|
US10434195B2
(en)
|
2015-08-03 |
2019-10-08 |
Emory University |
Methylsulfonamide derivatives and uses related thereto
|
|
KR102033920B1
(ko)
|
2016-02-23 |
2019-10-18 |
바이오라인알엑스 리미티드 |
급성 골수성 백혈병을 치료하는 방법
|
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
|
CN110590744B
(zh)
*
|
2019-07-03 |
2021-11-02 |
河南省人民医院 |
一种靶向趋化因子受体cxcr4的小分子类pet显像剂
|